Skip to content

Clinical trials

Phase 3 Myocardial Infarction trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 3 Country / region: India Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20062
20082
20091
20101
20111
20132
20151
20191
20201
20211
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated4
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Pfizer2
Sanofi2
AstraZeneca1
Boehringer Ingelheim1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
LIB Therapeutics LLC1
Mark Eisenberg1
National Institute of Allergy and Infectious Diseases (NIAID)1
Novartis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction18
Cardiovascular Diseases10
Stroke8
Acute Coronary Syndrome4
Hyperlipidemias3
Angina, Unstable2
Coronary Artery Disease2
Hypercholesterolemia2
Atherosclerosis1
COVID-191

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.